In this interview from AAO 2019, Dr. Ron Fellman discusses his recent work assessing outflow patterns in glaucoma.

This study compared the efficacy of a fixed-dose netarsudil/latanoprost combination therapy versus individual monotherapies for open-angle glaucoma and ocular hypertension.

In this interview from AAO 2019, Dr. Davinder Grover describes methods to manage tube-related hypotony.

Sequencing and timing of cataract surgery do not affect trabeculectomy success rates at 5 years, according this retrospective study.

In this interview from AAO 2019, Drs. John Shepherd and Mona Kaleem discuss vision rehabilitation for patients with glaucoma.

This week, costume contact lenses are removed in the emergency room, Genentech’s satralizumab and Iveric’s avacincaptad pegol advance through the pipeline and a Washington ophthalmologist receives $17.2 million to study aging eyes and the brain.

In this 1-Minute Video, Dr. Davinder Grover explains why corneal hysteresis is a vital sign for managing glaucoma.

These 2 calculators estimate the 5-year risk that an person with ocular hypertension will develop primary open-angle glaucoma.

Investigators assessed the safety and efficacy of Schlemm canal stenting in combination with cataract surgery in eyes with mild to moderate primary open-angle glaucoma (POAG).